Ocumension Therapeutics (HKG:1477)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
7.33
+0.37 (5.32%)
At close: Mar 27, 2026

Ocumension Therapeutics Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-268.27-379.79-402.64-259.99
Depreciation & Amortization
88.6157.5440.4613.9
Asset Writedown & Restructuring Costs
--3.183.18-
Loss (Gain) From Sale of Investments
-0.29-1.16-1.25-125.78
Loss (Gain) on Equity Investments
---13.33
Stock-Based Compensation
84.63139.73218.79188.12
Provision & Write-off of Bad Debts
0.650.350.68-
Other Operating Activities
-22.34-24.57-479.07
Change in Accounts Receivable
-38.93-7.65-33.28-31.15
Change in Inventory
-13.05-13-19.11-1.97
Change in Accounts Payable
-11.3449.5734.42-2.39
Change in Unearned Revenue
1.5-30.09-
Change in Other Net Operating Assets
-4.25-25-
Operating Cash Flow
-178.83-177.93-200.66-196.85
Capital Expenditures
-47.1-80.91-115.81-195.37
Sale (Purchase) of Intangibles
-183.05-280.96-194.19-469.44
Investment in Securities
470.4653.22522.86-697.79
Other Investing Activities
35.648.8616.2917.31
Investing Cash Flow
275.91-259.78229.15-1,345
Long-Term Debt Issued
46.55120--
Long-Term Debt Repaid
-163.5-14.25-9.15-3.82
Total Debt Repaid
-163.5-14.25-9.15-3.82
Net Debt Issued (Repaid)
-116.95105.75-9.15-3.82
Issuance of Common Stock
0.985.612.72684.73
Repurchase of Common Stock
-95.57-1.46-11-1.39
Other Financing Activities
-2.25-1.22-1.79-10.68
Financing Cash Flow
-213.79108.66-9.22668.85
Foreign Exchange Rate Adjustments
3.071.8425.56-35.81
Net Cash Flow
-113.63-327.2144.83-909.1
Free Cash Flow
-225.92-258.84-316.47-392.22
Free Cash Flow Margin
-54.14%-105.06%-199.09%-698.57%
Free Cash Flow Per Share
-0.33-0.40-0.50-0.65
Cash Interest Paid
2.251.221.790.57
Cash Income Tax Paid
0.32-0.030.41-
Levered Free Cash Flow
-344.38-480.3-404.46-580.44
Unlevered Free Cash Flow
-343.03-479.47-403.33-580.09
Change in Working Capital
-61.8233.15-12.88-35.5
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.